|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, November 11, 2016 ) Generic drugs have the same chemical formula, dosage form, potency, route of administration, quality, and intended use as that of patented branded drugs. They cost 80%-85% lesser than their branded counterparts and are available soon after the patent expiries of original drugs. However, they are similar to original drugs in terms of safety, quality, and effectiveness. Manufacturers need to apply for an Abbreviated New Drug Application (ANDA) approval to receive approval of generics.
Publisher's analysts forecast the global generic drugs market to grow at a CAGR of 10.53% during the period 2016-2020.
For more information about this report: http://www.reportsweb.com/global-generic-drugs-market-2016-2020 .
Covered in this report
The report covers the present scenario and the growth prospects of the global generic drugs market for 2016-2020. To calculate the market size, it considers revenue generated from the sales of simple generics, super generics, and biosimilars.
The market is divided into the following segments based on geography:
- Americas
- APAC
- EMEA
Publisher's report, Global Generic Drugs Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
- Teva Pharmaceuticals
- Sandoz
- Allergan
- Mylan
- Sun Pharmaceuticals
- STADA Arzneimittel
Request Sample Copy at http://www.reportsweb.com/inquiry&RW0001263458/sample .
Other prominent vendors
- Abbott
- Amgen
- Apotex
- Aspen
- AstraZeneca
- Aurobindo Pharma
- Baxter
- Berlin-Chemie
- Biocon
- Biogen
- Boehringer Ingelheim
- Celltrion
- Cipla
- Coherus Biosciences
- Dr. Reddy's Laboratory
- Daiichi Sankyo
- Eli Lilly
- Emcure Pharmaceuticals
- Eurofarma Laboratories
- Gedeon Richter
- Gilead Sciences
- GlaxoSmithKline
- Hospira
- Impax
- InnoPharma
- Intas Pharmaceuticals
- Jannsen
- Lupin
- Merck
- Mitsubishi Tanabe Pharma
- Momenta Pharmaceuticals
- Natco Pharma
- Nexus Pharmaceuticals
- Novo Nordisk
- Orchid Chemicals & Pharmaceuticals
- Parenteral Drugs India
- Par Pharmaceutical
- Pfizer
- Piramal (Abbott Laboratories)
- Roche Holdings
- Sanofi
- Synthon
- Towa
- Valeant Pharmaceuticals
- Zentiva
- Zhejiang Chira Medicine Chemicals
- Zhejiang Hisun Pharmaceutical
- Zydus Cadila Healthcare
Market driver
- Patent expiry of top-selling drugs
- For a full, detailed list, view our report
Market challenge
- Threat of counterfeit drugs
- For a full, detailed list, view our report
Market trend
- Outsourcing of drug development activities
- For a full, detailed list, view our report
Make an enquiry: http://www.reportsweb.com/inquiry&RW0001263458/buying .
ReportsWeb.com
Priya Sisodia
+1-646-491-9876
sales@reportsweb.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
